Read article - Gabriel Brooks, assistant professor of medicine and assistant professor of The Dartmouth Institute, says that pharmacogenetic testing for DPYD and UGT1A1 gene variants could be cost-effective in preventing severe chemotherapy-related toxicity based on the treatment of stage 3 colon cancer patients. Comments by Brooks are referenced in research reported at the 2021 Gastrointestinal Cancers Symposium.
Upcoming Events
- Preventing Overdiagnosis Webinar: Why cancer is our most feared disease. April 25, 2024
- Discovery Science Seminar Series April 29, 2024
- Microbiology & Immunology Seminar Series - Akhenaton-Andrew Dhafir Jones III, Ph.D. April 29, 2024
- Psychiatry Grand Rounds April 30, 2024
- Pediatric Grand Rounds May 1, 2024
- Thesis Defense (Kaesi Morelli) May 1, 2024
- Spring DEIB Series "Following the Arc towards Justice: An Editor's Perspective" May 1, 2024
- Spring DEIB Series "Following the Arc towards Justice: An Editor's Perspective" May 2, 2024
- M&I Thesis Defense - Leena Abdullah May 2, 2024
- Microbiology and Immunology Graduate Seminar May 2, 2024
- Dept. of Surgery Grand Rounds May 3, 2024
- PhD Thesis Presentation - Muhammad Abubakar Khan May 3, 2024